Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
5.34
+0.07 (1.33%)
At close: Mar 23, 2026, 4:00 PM EDT
5.34
0.00 (0.00%)
After-hours: Mar 23, 2026, 4:10 PM EDT

Harvard Bioscience Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2392999302,3221,1402,901
Market Cap Growth
559.68%-67.84%-59.94%103.71%-60.71%71.57%
Enterprise Value
271.34333.22932.242,3531,1832,944
Last Close Price
5.346.6921.1053.5027.7070.50
PE Ratio
--0.52-7.54-66.87-12.04-705.00
Forward PE
26.707.8717.5823.2617.8722.03
PEG Ratio
-1.031.031.031.031.03
PS Ratio
2.723.469.8820.6810.0624.39
PB Ratio
1.7221.7814.6831.7715.7834.78
P/TBV Ratio
1.732.161.453.111.593.41
P/FCF Ratio
43.0854.67-772.40189.68-2601.9543292.13
P/OCF Ratio
35.0244.45645.81165.50989.282298.39
EV/Sales Ratio
3.143.859.9020.9610.4424.76
EV/EBITDA Ratio
36.46-7.82985.46264.601843.36303.95
EV/EBIT Ratio
181.13-6.86-150.101242.26-170.701425.14
EV/FCF Ratio
49.6060.91-774.29192.23-2701.9243945.29
Debt / Equity Ratio
3.113.110.100.490.670.62
Debt / EBITDA Ratio
-1.00-1.0045.814.6584.495.88
Debt / FCF Ratio
7.817.81-35.993.38-123.84850.15
Net Debt / Equity Ratio
2.492.490.620.510.690.59
Net Debt / EBITDA Ratio
-0.80-0.8041.474.1777.475.07
Net Debt / FCF Ratio
6.246.24-32.583.03-113.55733.42
Asset Turnover
0.840.840.710.790.740.75
Inventory Turnover
1.661.661.641.811.942.06
Quick Ratio
1.121.120.350.770.911.17
Current Ratio
2.202.200.821.852.202.43
Return on Equity (ROE)
-173.44%-169.98%-26.18%-10.83%-15.12%-3.12%
Return on Assets (ROA)
-46.52%-46.51%-4.91%1.50%-4.64%1.38%
Return on Invested Capital (ROIC)
-51.83%-51.82%-5.28%1.62%-5.03%1.51%
Return on Capital Employed (ROCE)
-74.86%-74.86%-6.81%1.63%-5.35%1.52%
Earnings Yield
-24.06%-191.39%-13.27%-1.50%-8.30%-0.14%
FCF Yield
2.32%1.83%-0.13%0.53%-0.04%0.00%
Buyback Yield / Dilution
0.04%0.04%0.02%0.07%0.09%0.01%
Updated Mar 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q